Critical Care
RSSArticles
-
A Guide to When and How to Stop CPR
In cardiopulmonary arrest situations, the mnemonic CEASE (Clinical features, Effectiveness, Ask, Stop, Explain), provides a guide for clinicians on how to discontinue resuscitative efforts and effectively communicate with other clinicians and families.
-
Survival in ARDS Can Be Predicted By Driving Pressure
Statistical models were applied to several large trials of ARDS patients undergoing lung protective ventilation strategies and found that decreases in driving pressure, or Δ P, were strongly associated with increased survival.
-
Multiple Factors Contribute to Recovery of Physical Function After Critical Illness
Physical function after critical illness is influenced by clinical, physiological, and psychological factors that suggest a need for comprehensive interventions to promote recovery and quality of life.
-
Nasal Screening for MRSA: The New Basis for De-escalation of Empiric Antibiotics?
The high negative predictive value of a negative nasal screen for methicillin-resistant Staphylococcus aureus suggests these patients do not have lower respiratory tract infections caused by the organism.
-
Post-ICU Stress Symptoms Are Associated with Increased Acute Care Service Utilization for at Least One Year
In this prospective, longitudinal study of adult medical-surgical ICU patients, in-hospital substantial acute stress symptoms were associated with a greater risk of rehospitalization within 1 year post-ICU discharge; those with substantial post traumatic stress disorder symptoms at 3 months post-ICU also had a greater risk of future emergency department visits within the year.
-
The Quandry Over Preventing Delerium in Acute Respiratory Distress Syndrome
A significantly higher incidence of delirium was found in patients with acute respiratory distress syndrome (ARDS).
-
Communicating About Prognosis in the ICU
Effectively communicating a prognosis to a patient’s surrogates in the ICU can be challenging.
-
Post Intensive Care Syndrome: Risk Factors and Prevention Strategies
Each year, approximately 800,000 patients in the United States develop an illness that results in admission to an ICU and need for mechanical ventilation.
-
Peramivir: A Newly Approved Antiviral for Treatment of Influenza
Peramivir (Rapivab™) was recently approved by the FDA in December 2014 for treatment of acute uncomplicated influenza within two days of symptom onset. This newly approved antiviral is a neuraminidase inhibitor (NI) similar to oseltamivir and zanamivir but the first to be approved in an injectable formulation.1 Peramivir has been licensed in Japan (as Rapiacta) and South Korea (as PeramiFlu) since 2010. In addition, it has been used in the United States on an emergency basis during the 2009 H1N1 flu pandemic.
-
Multicenter Quality Improvement Project Resulted in a 23% Reduction in Medical Errors
SYNOPSIS: Implementation of a quality improvement project focused on handoffs reduced medical errors by 23% and preventable adverse events by 30%.